Lv2
156 积分 2025-03-25 加入
Sacituzumab Govitecan-hziy in Breast Cancer
10天前
已完结
Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 Antibody
11天前
已完结
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study
18天前
已完结
Safety, tolerability, and dosimetry of TLX591 with best standard of care in patients with PSMA-expressing metastatic castration resistant prostate cancer (ProstACT SELECT preliminary results)
22天前
已关闭
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
23天前
已完结
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
24天前
已完结
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
25天前
已关闭
Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases
28天前
已完结
Development of [89Zr]Zr-DFO-hu3F8 and [225Ac]Ac-DOTA-hu3F8 Theranostic Pairs Targeting GD2 in Neuroblastomas
29天前
已完结
Synthesis and Preclinical Evaluation of a Novel Radiolabeled Anti-Caudin-18.2 Humanized VHH-Based Recombinant Antibody as Radioimmunotherapy Candidate for Gastric Cancer
1个月前
已关闭
皖公网安备34019202002308
